Lifecore Biomedical Inc. (NASDAQ: LFCR) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT LIFECORE BIOMEDICAL INC.

Lifecore Biomedical Inc. (NASDAQ: LFCR)
Listen to this Section


$5.99
+0.0500 ( +0.50% ) 46.0K

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

Market Data


Open $5.99
Previous Close $5.94
Volume 46.0K
Market Cap $220.67M
Day Range $5.83 - $6.10
52 Week Range $3.68 - $8.90
Shares Outstanding 37.03M
Change % +0.50%
Net Change ▲ 0.0500
Insider Ownership 0.09%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 1996
Country United States

Insider Ownership Transactions

Total Amount Purchased: 584,531.00

Date Type Amount Purchased Purchaser
2024-10-07 Buy 1311312.00 Kiper Christopher S
2024-10-07 Buy 122930.00 WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
2024-07-10 Sale -30000.00 Barbarosh Craig A.
2024-07-10 Sale -30000.00 Diradoorian Raymond H
2024-07-10 Sale -30000.00 EDWARDS JEFFREY L
2024-07-10 Sale -30000.00 Kiper Christopher S
2024-07-10 Sale -30000.00 Calloway Nathaniel
2024-07-10 Sale -30000.00 HOUDE LOVAS KATRINA
2024-07-10 Sale -30000.00 OBUS NELSON
2024-07-10 Sale -30000.00 Schechter Joshua

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 90 Oct 04, 2024
8-k 8K-related 48 Oct 04, 2024
8-k 8K-related 13 Sep 23, 2024
def Proxies and info statements 22 Sep 23, 2024
144 Insider transactions 1 Sep 20, 2024
4/a Other 1 Sep 16, 2024
8-k 8K-related 13 Sep 12, 2024
3 Insider transactions 3 Sep 05, 2024
4 Insider transactions 1 Sep 05, 2024
8-k 8K-related 17 Aug 29, 2024

Latest News


× Before browsing our site, please accept our cookies policy